Creating a wearable device to treat metastatic triple-negative breast cancer
DEVELOPMENT OF A WEARABLE, NON-INVASIVE, TREATMENT DEVICE FOR METASTATIC TRIPLE-NEGATIVE BREAST CANCER (TNBC)
This study is testing a new, easy-to-wear device that uses gentle electric fields to help treat metastatic triple-negative breast cancer, aiming to boost your immune system and work alongside other treatments to improve your health.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Embiosys INC. NIH-funded |
| Lab location | 1 site (North Andover, UNITED STATES) |
| Project ID | NIH-11086646 on NIH RePORTER |
What this research studies
This research focuses on developing a non-invasive, wearable device that utilizes induced electric field (iEF) technology to treat metastatic triple-negative breast cancer (TNBC). The device aims to enhance immune responses and complement existing treatments by using low-intensity electromagnetic fields. In preclinical models, this approach has shown promise in reducing tumor burden and metastasis while increasing the presence of beneficial immune cells. Patients may benefit from this innovative treatment option that could improve outcomes for those with limited current therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with metastatic triple-negative breast cancer who have limited treatment options.
Not a fit: Patients with non-metastatic breast cancer or those who do not have triple-negative breast cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new, effective treatment option for patients with metastatic triple-negative breast cancer.
How similar studies have performed: While the approach of using wearable devices for cancer treatment is innovative, similar technologies utilizing electromagnetic fields have shown promise in preclinical studies.
Where this research is happening
North Andover, UNITED STATES
- Embiosys INC. — North Andover, United States (Active)
Researchers
- Principal investigator: Barron, Christopher — Embiosys INC.
- Study coordinator: Barron, Christopher
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.